Skip to main content
JDHIF logo

JD Health International Inc. (JDHIF) Stock Price & Analysis

JD Health International Inc. (JDHIF) — price $4.79 (0.00%), as of the Nov 19, 2026 trading session; market cap $15.3B.

Educational signal · not a buy or sell recommendation · How to read this

$4.79 $0.00 (0.00%) Market Cap $15.3B

JD Health International Inc. · JDHIF · Healthcare · Pharmaceutical Retailers

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China.

Price as of Nov 19, 2026

Key Statistics

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$4.79
Change on the day0.00%
52-week range$4.38–$8.75
Market capitalisation$15.3B
Price / earnings (trailing)15.18
Shares traded on the day100
Beta (volatility vs the S&P 500)1.22

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $4.38, high $8.75, latest $4.79. $8.75 $4.38 high $8.75 Oct 17, 2025 Nov 19, 2026 · $4.79 $8.03Oct 17, 2025$8.75Oct 31, 2025$8.75Nov 14, 2025$8.75Nov 28, 2025$7.07Dec 12, 2025$7.58Dec 26, 2025$7.58Jan 9, 2026$7.58Jan 23, 2026$7.58Feb 6, 2026$7.58Feb 20, 2026$6.15Mar 6, 2026$6.15Mar 20, 2026$6.15Apr 2, 2026$6.15Apr 17, 2026$5.85May 1, 2026$5.85May 15, 2026$5.85May 29, 2026$5.85Jun 12, 2026$5.85Jun 26, 2026$5.85Jul 10, 2026$5.85Jul 24, 2026$5.85Aug 7, 2026$4.85Aug 21, 2026$4.85Sep 4, 2026$4.38Sep 18, 2026$4.38Oct 2, 2026$4.59Oct 16, 2026$4.79Oct 30, 2026$4.79Nov 13, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for JD Health International (JDHIF): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

3 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Favorable read

Read on: Sep 28, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Strong
Margin of Safety Undervalued
Profit Margin Neutral
Revenue Growth Strong
Debt/Equity Strong
ROE Neutral
Gross Margin Neutral

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 10, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is JD Health International (JDHIF), and what does it report?

Short answer · as of

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. JD Health International Inc. (JDHIF) is classified as Healthcare / Pharmaceutical Retailers. Headquarters: Jingdong Headquarters, Beijing, 101111, China. It employs 6,018 people. In Q2 FY2026 it reported revenue of CN¥40.33B and net income of CN¥3.39B. The market values it at $15.3B.

2 · Latest results

What do the latest results show for JD Health International (JDHIF)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of CN¥40.33B. Against analyst estimates the company has EPS beat 3 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026CN¥40.33BCN¥3.39BCN¥1.09 (diluted)
Q4 FY2025CN¥37.52BCN¥2.73BCN¥0.84 (diluted)
Q2 FY2025CN¥35.29BCN¥2.60BCN¥0.81 (diluted)
Q4 FY2024CN¥29.82BCN¥2.12BCN¥0.67 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for JD Health International (JDHIF)?

Short answer · as of

The distress and quality screens read Altman Z 4.25 · Piotroski F 7. Trailing ratios: ROE 10.4% · ROA 3.7% · current ratio 2.69.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held JDHIF in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported JDHIF in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

JD Health International Healthcare Stock: Key Questions Answered

Research dated 2026-09-13; the full attribution is under Sources. The last question is answered from this page's own dated data, not from the research.

How does JD Health make money beyond selling medicines?

JD Health monetizes consultations, referrals, home care, health checks, advertising, technical services, digital health solutions and marketplace activity. Medical devices, offline clinics and payment support extend the platform beyond online pharmacy transactions.

What is the JDHIF stock price today?

The last price recorded for JD Health International Inc. (JDHIF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 18 figures on this page — 16 from Financial Modeling Prep (FMP) and 2 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-13), by section of the research

  • FAQ: How does JD Health make money beyond selling medicines?: Business description
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.